http://www.medicalnewstoday.com/medicalnews.php?newsid=65634&nfid=rssfeeds
LIALDA is available to patients by prescription for oral administration in dosages of 2.4 g/day and 4.8 g/day, allowing patients to take as few as two tablets once daily. Other currently available mesalamines require three to four times daily dosing and six to 16 pills a day. A study found that patients who are not compliant with their mesalamine medications have a five-fold greater risk of disease flares, a serious worsening of symptoms, than compliant patients.
Related Posts
Pharmacy Benefit Managers Are Not Much More Than “Complex Well-Greased Algorithmic Human Scoring Machines” That Deny or Allow Access To Drugs To Create/Substantiate Big Corporate Profits
So let’s get down to what’s really happening here. Once upon a time the PBM models were a diff[...]
Optum/United Healthcare Quietly Sold Optum Hospice to Compassus in December of 2016-And Compassus Is Now Contracted Under Optum Services to Manage the Facilities, Services and Provide the OptumCare Doctors
Optum certainly kept this very quiet when they sold their hospice facilities to Compassus and I don’[...]
Algorithms, Scoring Metrics, Privacy and more in today’s Healthcare business world–The Healthcare Algo Cartel
This is a video of a recent presentation I did at the 74th Annual AAPS (American Association of Phys[...]
Pharmacy Benefit Managers Invade Medical Records and Electronically Connect Cash Patients to RX Discount Cards-OptimizeRX-to SingleCare to OptumRX
This should not really come as a big surprise as what hasn’t the pharmacy benefit managment business[...]
“One Trick Algo World” Needs to be Licensed and Indexed–Spurious Correlations “For Profit” Are Out of ControlWith prediction tools and apps being all the rage today, their reliability and accuracy are not alwa[...]
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.